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Abstract
In the era of genomics, the number of genes linked to mitochondrial disease has been
quickly growing, producing massive knowledge on mitochondrial biochemistry.
LYRM4 gene codifies for ISD11, a small protein (11 kDa) acting as an iron-sulfur clus-
ter, that has been recently confirmed as a disease-causing gene for mitochondrial disor-
ders. We present a 4-year-old girl patient, born from non-consanguineous healthy
parents, with two episodes of cardiorespiratory arrest after respiratory viral illness with
progressive decreased activity and lethargy, at the age of 2 and 3 years. She was
asymptomatic between crisis with regular growth and normal development. During
acute events of illness, she had hyperlactacidemia (maximum lactate 5.2 mmol/L) and
urinary excretion of ketone bodies and 3-methylglutaconic acid, which are normalized
after recovery. A Next Generation Sequence approach with a broad gene panel
designed for mitochondrial disorders revealed a novel probably pathogenic variant in
homozygosity in the LYRM4 gene [p.Tyr31Cys (c.92A>G)] with Mendelian segrega-
tion. Functional studies in the skeletal muscle confirmed a combined deficiency of the
mitochondrial respiratory chain (I, II, and IV complexes). To our knowledge, this is
the third case of LYRM4 deficiency worldwide and the first with 3-methylglutaconic
aciduria, not reported in any Fe-S cluster deficiency. Remarkably, it appears to be no
neurological involvement so far, only with life-threating acute crisis triggered by
expectably benign autolimited illnesses. Respiratory chain cofactors and chaperones
are a new field of knowledge and can play a remarkable effect in system homeostasis.
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1 | INTRODUCTION
In the era of genomics, the classical interpretation that mito-
chondrial disorders comprised those with a deficiency in one
or more subunits of the respiratory chain was broadened and
nowadays includes defects of complex assembly, mitochon-
drial DNA transcription, translation and maintenance,
Abbreviations: 3-HMG, 3-hydroxymethylglutaric acid; 3-MGA,
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IVA, 3-hydroxyisovaleric acid; ACP, acyl carrier protein; COX,
cytochrome oxidase; CS, citrate synthetase; CSF, cerebrospinal fluid; ISC,
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membrane function and import, mitochondrial fusion and fis-
sion, and cofactor biosynthesis (eg, coenzyme Q10, lipoic acid,
or iron-sulfur clusters).1,2 Iron-sulfur clusters (ISCs) are crucial
cofactors for mitochondrial function and facilitate the electron
transport chain. More than 50 different ISCs have been identi-
fied and localized in mitochondria, nucleus, and cytosol.3 Mito-
chondrial ISCs are synthesized in the mitochondrial matrix
although mitochondria also interfere in nuclear ISC assembly.4
Extramitochondrial functions include DNA replication, damage
repair, and telomere maintenance.5
ISC biogenesis machinery is complex and not fully under-
stood. It first requires the synthesis of a [2Fe-2S] cluster by
cysteine desulfurase complex (NFS1-ISD11-ACP), which
allows cysteine to act as sulfur donor (desulfuration of cysteine
to alanine) while frataxin may act as the iron donor.3,4,6,7 This
process relies on the action of the iron-sulfur cluster assembly
scaffold protein (ISCU) and electron chain of NAD(P)H, ferre-
doxin reductase, and ferredoxin.4,8 Along with chaperones,
ISCU then releases the ISC to apoproteins in an energy-
dependent reaction.4 Later, [4Fe-4S] clusters will be formed,
and by the action of several ISC targeting factors, they will be
inserted into specific apoproteins.4
Twenty known genes have a direct role in mitochondrial
ISC biogenesis and 17 ISC-related genes are implicated in
human disease.9,10 For example, ISCU interacts with frataxin
through ISD11, and frataxin deficiency has a negative impact
on ISCs' assembly.11
ISD11 is a 11 kDa protein found at both mitochondria and
nucleus3 and is codified by the well-conserved LYR motif-
containing protein 4 gene (LYRM4) located in the chromosome
6p25.1. As an early intervenient in ISC biogenesis, ISD11 defi-
ciency can have a negative interference in multiple systems and
results in combined OXPHOS deficiency (MIM#615595—
COXPD19). ISD11 also plays a key role in iron homeostasis as
a controller of the intracellular iron trafficking, and its defi-
ciency leads to mitochondrial iron overload.3,4,11,12
To our knowledge, there are only two published patients
with LYRM4 deficiency.9 They were consanguineous first-
degree cousins with Lebanese/Sirian origin and a missense
mutation (c.203G>T, p.R68L) leading to a nonfunctional
NFS1-ISD11 complex. The proband had a neonatal failure
to thrive severe lactic acidosis, metabolic acidosis, respira-
tory distress, apnea, and elevated liver enzymes, all of which
progressively improved, remaining healthy at the age of
20 years. His female cousin had respiratory distress right
after birth and hyperlactacidemia; at 2 months of life she had
a similar crisis, evolving to respiratory arrest and later died
in intensive care unit. Organic acid analysis showed lactate
excretion and ketosis, without other metabolites. Both had
combined deficiency of complexes I, II, and III in skeletal
muscle biopsy.
2 | METHODS
Chromatography of urinary organic acids was performed by gas
chromatography mass spectrometry; after acidification, salting
and extraction with trimethylsilyl in a sample volume are equiva-
lent to a creatinine volume of 5 mmol/L. Two internal standards
were used (3-phenylbutyric acid and 3-tricarballylic acid).
Histological studies were performed on tissue from the
deltoid muscle collected by open biopsy under general anes-
thesia. Sample was preserved in saline-moistened gauze and
immediately processed. Histological studies included modi-
fied Gomori trichrome, cytochrome oxidase (COX), and suc-
cinate dehydrogenase stains.
Spectrophotometric measurements of respiratory chain
enzymes and citrate synthase were carried out in skeletal mus-
cle homogenates as previously described,13 in a sample of
deltoid muscle, immediately frozen at −80C until analysis.
Genetic studies were performed by a Next Generation
Sequence (NGS) approach with a gene panel designed for mito-
chondrial disorders including 209 nuclear genes known to be
associated with mitochondrial diseases (Table S1). Genes of
interest were captured using the SureSelectQXT kit (Agilent
Technologies), followed by sequencing on the Illumina MiSeq
platform. This study was approved by the Ethics Committee of
Centro Hospitalar do Porto. Variants were filtered taking into
account: (a) the type of pathogenic variant (missense, frameshift,
stop-gain or stop-loss, and splice-site variants), (b) in silico pre-
dictors (SIFT, PolyPhen-2, MutationTaster) and their presence
in databases (dbSNP, 1000 Genomes, HGMD professional,
ClinVar, ExAC, OMIM, gnomAD), and (c) the population fre-
quency [variants with a minor allele frequency (MAF) <1% in
the 1000 Genomes Project (http://www.1000genomes.org) and
Exome Variant Server databases (http://evs.gs.washington.edu)
were filtered out]. Sanger sequencing was used to validate the
mutation and to studyMendelian segregation in parents.
3 | CASE REPORT
We present the case of a 4-year-old girl, first child of a non-
consanguineous healthy Portuguese couple, with normal growth
and neurodevelopment. She had an episode of cardiorespiratory
arrest at the age of 2 years after a respiratory viral infection.
Microbiological studies identified respiratory syncytial virus
(RSV) in respiratory secretions and Human herpesvirus
6 (HVV6) in cerebrospinal fluid (CSF). Work-up during recov-
ery showed a persistent increased lactate (maximum 5 mmol/L,
normal range [NR] <2.0 mmol/L). Her electrocardiogram,
echocardiogram, and brain magnetic resonance imaging (MRI)
were normal. She was discharged with pending metabolic
results and was lost in the follow-up.
At the age of 3 years, she was admitted to our hospital after
cardiac arrest following acute respiratory insufficiency. Similar to
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FIGURE 1 Chromatograms of urinary organic acids showing excretion of 3-methylglutaconic acid during acute crises: A, cardiorespiratory
arrest, B, during febrile mild illness without clinical deterioration, and C, during an intercrisis interval. IS1, internal standard 1 (3-phenylbutyric acid);
IS2: internal standard 2 (3-tricarballylic acid)
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the first episode history, parents reported nasal discharge, cough,
fever, and reduced appetite for the previous 4 days, with a pro-
gressive decrease of activity. That day she had been lethargic and
presented with difficulty to breath prior to the cardiorespiratory
arrest.
After resuscitation, apart from pulmonary auscultation with
rhonchi, her physical examinationwas normal. Diagnostic investi-
gation revealed persistently high lactate (2.3-4.1 mmol/L, NR
<2.0 mmol/L), normal blood and CSF counts (lactate in CSFwas
not performed), negative C-reactive protein, and sterile blood cul-
ture. She had no hypoglycemia and her initially elevated liver
enzymes and creatine kinase (CK) (3-4 times the upper normal
limit) rapidly returned to normal values. Chest X-ray showed no
pneumoniae and RSV was isolated in respiratory secretions. Car-
diac evaluation (electrocardiogram, echocardiogram, and continu-
ous electrocardiographic recording) was normal and an
immunodeficiencywas excluded (normal immunoglobulins, flow
cytometry, and adequate response to tetanus and pneumococcus
vaccines).
Plasma amino acids were normal and acylcarnitines showed
only low free carnitine (6.5 μM, NR 19-48 μM) with normal
acetylcarnitine. Urinary organic acids on admission showed
ketonuria and moderate excretion of 3-methylglutaconic acid
(3-MGA) with 154 μmol/mmol creatinine (NR <19 μmol/mmol
creatinine) andmild excretion of 3-hydroxyisovaleric acid (3-OH-
IVA) with 85 μmol/mmol creatinine (NR 10.4-67.0 μmol/mmol
creatinine) and 3-hydroxymethylglutaric acid (3-HMG) with
93 μmol/mmol creatinine (NR 6.2-49.7 μmol/mmol creatinine),
as shown in Figure 1.
At this point, she enrolled in a research study for the diagnosis
of mitochondrial disorders by an NGS approach. Retrieving infor-
mation from the first episode showed that 2 weeks after the cardio-
respiratory arrest she had mild excretion of 3-MGA
(27 μmol/mmol creatinine) accompanied bymultiple othermetab-
olites, such as 4-hydroxyphenyllactic and 3-hydroxyadipic acids
and traces of 3-methylglutaric, 2-OH-IVA, and sebacic acids.
After 5 days on mechanical ventilation and vasoactive
support, she was weaned to spontaneous breathing and after
24 hours on noninvasive ventilation. Asymptomatic and
with a normal neurologic examination, she was discharged
after 2 weeks under carnitine per os. After recovery, lactate
and organic acids completely normalized as well as carnitine
levels, even after suspension of carnitine supplementation.
A close follow-up was guaranteed. During the subsequent
episode of fever with reduced oral intake, without evidence of
significant general status or neurological deterioration, CK levels
and liver enzymes were normal but her urinary profiling again
revealed marked ketosis and mild excretion of lactate, 3-MGA
(129 μmol/mmol creatinine), 3-OH-IVA (162 μmol/mmol cre-
atinine), and 3-HMG (102 μmol/mmol creatinine) (Figure 1).
She has been admitted again to the pediatric ward for two other
occasions: one for fever with reduced oral intake and lethargy
and another for a wheezing episode with hypoxia, both with full
recovery without any complications.
During an intercritical and asymptomatic interval, meta-
bolic re-evaluation had no hyperlactacidemia, ketosis, ele-
vated CK, or altered organic acid excretion (Figure 1).
At the age of 4 years, she currently attends preschool and
has ballet lessons, which she completes without difficulty
and both parents and patient do not report any complaints.
Her physical examination remains normal.
Currently, the patient is not under any treatment. Follow-
up includes regular clinical and biochemical evaluations
along with general recommendations. Special caution is
given during catabolic states with admittance and intrave-
nous fluid intake (5% dextrose in normal saline). Brain MRI
evaluation was delayed pondering the general anesthetic risk
vs her normal neurological status.
4 | RESULTS
NGS for mitochondrial disorders revealed a probably patho-
genic novel variant in homozygosity in the LYRM4 gene [p.
Tyr31Cys (c.92A>G)], with heterozygous parents for the
same variant. The pathogenicity was predicted bio-
informatically by SIFT, PolyPhen-2, and MutationTaster as
probably pathogenic variants. The p.Tyr31Cys variant
affects an amino acid that is highly conserved in different
species through evolution (Figure 2) and was absent in
100 alleles from Portuguese subjects and is not reported in
public SNP databases, including dbSNP, the Exome Variant
Server, and gnomAD (without any reported homozygote).
A muscle biopsy was performed. Histology showed occa-
sional atrophy of muscle fibers and frequent accumulation of
lipid droplets, without variation on fiber size or COX negative or
red-ragged fibers. Functional assay of the respiratory chain
showed elevated citrate synthetase activity (354.3 nmol/min/mg,
NR 85.0-180 nmol/min/mg) and confirmed the diagnosis with
the evidence of a combined deficiency of complexes I, II, and IV
with 40, 23, and 31% of residual activity, respectively (Table 1).
p.Tyr31Cys
Human          MAASSRAQVLSLYRAMLRESKRFSAYNYRTYAVRRIRDAF
Zebrafish      MASCSRAQVISLYRMLMKESKKFPSYNYRTYALRRVKDGF
Chicken        MAASSRAQVLRLYRALLRESQRFSGYNYRTYAIRRIRDAF
Pig            MAASSRAQVLDLYRAMLRESKHFSAYNYRTYAIRRIRDAF
Cow            MAASSRAQVLDLYRAMLRESKRFGAYNYRTYAIRRIRDAF
Goat           MAASSRAQVLDLYRAMLRESKRFGAYNYRTYAIRRIRDAF
Horse          MAASSRAQVLDLYRAMLRESKHFSAYNYRTYAVRRIRDAF
Rat            MAASSRAQVLDLYRAMMRESKHFSAYNYRMYAVRRIRDAF
               **  *****  ***    **  *  **** ** **  * *
FIGURE 2 Conservation of p.Tyr31 across species. The amino
acid sequence of 1-40 of human LYRM4 is shown and compared to the
corresponding sequences of eight species. Amino acid positions
identical to human genome are represented as *. The p.Tyr31Cys
variant is conserved among all species examined
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5 | DISCUSSION
This case broadens the phenotype knowledge on ISD11 defi-
ciency being the third case worldwide with a novel pathogenic
variant on LYRM4. Assumptions based on a small series must
be cautious, but within these three patients, rapid clinical status
deterioration with respiratory failure and arrest in the course of
an infectious intercurrence appear to be a common feature.
When surviving these acute crises, apparently asymptomatic
periods follows. Lim et al hypothesized that hepatic
cystathionase activity is prone to be lower during the neonatal
period subsequent to low availability of cysteine as sulfur
donor, explaining both neonatal onset and ability to survive
after this period.9 However, this justification does not account
for the late onset and repeated episodes on this patient.
As in other cases with ISD11 deficiency, hyperlactacidemia
and ketosis where present, although not as elevated as reported.
Combined respiratory chain deficiency is similar to findings in
other patients with iron-sulfur deficiencies.
A particular characteristic of this patient is the consistent
and significant (>40 μmol/mmol creatinine) excretion of
3-MGA during acute events, not previously reported in
patients with any Fe-S cluster deficiency. 3-MGA-uria can be
found in various inborn metabolic disorders commonly along
with excretion of other metabolites (fatty acid oxidation disor-
der, methylmalonic and propionic aciduria, glycogen storage
disease, or urea cycle disorder). It can be a feature of mito-
chondrial disorders present in about 10% of patients,14 but
usually is not the prominent hallmark of disease and excretion
is only slightly elevated and as an accompanying finding.15 It
represents not an impairment on the leucine pathway but an
alternative route for acetyl-CoA degradation.16
Inborn errors of metabolism with 3-MGA-uria as discrimina-
tive feature (isolated, significantly or repeatedly elevated) can
be classified as primary or secondary 3-MGA-uria.15 Primary
3-MGA-uria is caused by 3-methylglutaconyl-CoA hydratase
deficiency, an inborn error of the leucine pathway. Known dis-
eases with secondary 3-MGA-uria can be due to the follow-
ing14,15,17-19: (a) defective phospholipid remodeling: Barth
syndrome (TAZ gene) and MEGDEL syndrome (SERAC1
gene); (b) mitochondrial membrane-associated disorder: Costeff
syndrome (OPA3), TMEM70 defect (TMEM70), and DCMA
syndrome (DNAJC19); (c) unknown mechanism: Sengers syn-
drome (AGK), CLPB deficiency (CLPB), TIMM50 deficiency
(TIMM50), HTRA2 defect (HTRA2), and short-chain enoyl-
CoA hydratase deficiency (ECHS1).
This is the first case of Fe-S cluster with 3-MGA-uria,
extending the differential diagnosis of 3-MGA-uria as the
presenting feature.
Being a disorder related to iron metabolism, with the pos-
sibility to induce iron overload on tissues and storage deple-
tion, evaluation of ferritin, transferrin, soluble transferrin
receptor, or hepcidin may help understand the impact on the
dynamics of iron metabolism, despite no evidence of
impaired iron homeostasis in our patient so far.
Since cysteine acts the major sulfur donor, supplementa-
tion with this nonessential amino acid can be beneficial,
especially during periods of higher energy requirement. The
rationale for treatment with L-cysteine or N-acetylcysteine is
supported by studies on patients with mitochondrial disor-
ders with some benefit in those with translation-related
defects.20 It can be expected that a corresponding reduction
in iron overload diminishes its deleterious effects.
Raised awareness and a low threshold to hospital admit-
tance in patients with ISD11 deficiency may be crucial to
improve survival. Routine neurological and neuro-
development evaluation must be granted.
This case illustrates the importance of metabolic work-up to
be performed as soon as possible, while the patient is acutely
ill, as it may be a unique opportunity to diagnose a critical con-
dition. Moreover, life-threatening events disproportional to
symptoms and medical history should elicit the possibility of
energy-related inherited metabolic disorder. Acute presenta-
tions of mitochondrial disorders will become more common
with the improved diagnostic yield of genetic studies.
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TABLE 1 Respiratory chain functional assay in skeletal muscle
Measured
activity
(nmol/min/mg
NPC/CS)
Residual
activity (%)
Reference
values
(nmol/min/mg
NPC/CS)
Complex I 8.0 40 8.8-30.8
Complex II 5.4 23 12.0-35.0
Complex III 21.1 50 22.2-62.2
Complex II + III 1.3 17 2.6-12.0
Complex IV 7.1 31 11.5-34.5
Abbreviations: CS, citrate synthetase; NPC, noncollagenous proteins.
COELHO ET AL. 15
COMPLIANCE WITH ETHICAL STANDARDS
The study “Genetic Defects of Mitochondrial Diseases: a Next
Generation Sequencing Approach” (FCT PTDC/DTP-
PIC/2020/2014) was approved by the Ethics Committee of Cen-
tro Hospitalar do Porto (REF. 2016.194(164-DEFI/153-CES).
Informed consent from patient's parents was obtained.
ORCID
Margarida Paiva Coelho https://orcid.org/0000-0002-
6471-4067
REFERENCES
1. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases.
N Engl J Med. 2003;348:2656-2668. https://doi.org/10.1056/
NEJMra022567.
2. Liang C, Ahmad K, Sue CM. The broadening spectrum of mito-
chondrial disease: shifts in the diagnostic paradigm. Biochim
Biophys Acta. 2014;1840:1360-1367. https://doi.org/10.1016/j.
bbagen.2013.10.040.
3. Shi Y, Ghosh MC, Tong W-H, Rouault TA. Human ISD11 is
essential for both iron-sulfur cluster assembly and maintenance of
normal cellular iron homeostasis. Hum Mol Genet. 2009;18:3014-
3025. https://doi.org/10.1093/hmg/ddp239.
4. Lill R, Hoffmann B, Molik S, et al. The role of mitochondria in
cellular iron–sulfur protein biogenesis and iron metabolism. Bio-
chim Biophys Acta. 2012;1823:1491-1508. https://doi.org/10.
1016/j.bbamcr.2012.05.009.
5. Maio N, Rouault TA. Iron–sulfur cluster biogenesis in mammalian
cells: new insights into the molecular mechanisms of cluster deliv-
ery. Biochim Biophys Acta. 2015;1853:1493-1512. https://doi.org/
10.1016/j.bbamcr.2014.09.009.
6. Angerer H, Schönborn S, Gorka J, et al. Acyl modification and
binding of mitochondrial ACP to multiprotein complexes. Biochim
Biophys Acta. 2017;1864:1913-1920. https://doi.org/10.1016/j.
bbamcr.2017.08.006.
7. Cory SA, Van Vranken JG, Brignole EJ, et al. Structure of human
Fe–S assembly subcomplex reveals unexpected cysteine
desulfurase architecture and acyl-ACP–ISD11 interactions. Proc
Natl Acad Sci U S A. 2017;114:E5325-E5334. https://doi.org/10.
1073/pnas.1702849114.
8. Cai K, Tonelli M, Frederick RO, Markley JL. Human mitochon-
drial ferredoxin 1 (FDX1) and ferredoxin 2 (FDX2) both bind cys-
teine desulfurase and donate electrons for iron–sulfur cluster
biosynthesis. Biochemistry. 2017;56:487-499. https://doi.org/10.
1021/acs.biochem.6b00447.
9. Lim SC, Friemel M, Marum JE, et al. Mutations in LYRM4,
encoding iron–sulfur cluster biogenesis factor ISD11, cause defi-
ciency of multiple respiratory chain complexes. Hum Mol Genet.
2013;22:4460-4473. https://doi.org/10.1093/hmg/ddt295.
10. Vanlander AV, Van Coster R. Clinical and genetic aspects of
defects in the mitochondrial iron–sulfur cluster synthesis pathway.
J Biol Inorg Chem. 2018;23:495-506. https://doi.org/10.1007/
s00775-018-1550-z.
11. Shan Y, Napoli E, Cortopassi G. Mitochondrial frataxin interacts
with ISD11 of the NFS1/ISCU complex and multiple mitochon-
drial chaperones. Hum Mol Genet. 2007;16:929-941. https://doi.
org/10.1093/hmg/ddm038.
12. Saha PP, Srivastava S, Praveen Kumar SK, Sinha D, D'Silva P.
Mapping key residues of ISD11 critical for NFS1-ISD11 sub-
complex stability: implications in the development of mitochon-
drial disorder, COXPD19. J Biol Chem. 2015;290:25876-25890.
https://doi.org/10.1074/jbc.M115.678508.
13. DiMauro S, Servidei S, Zeviani M, et al. Cytochromec oxidase
deficiency in leigh syndrome. Ann Neurol. 1987;22:498-506.
https://doi.org/10.1002/ana.410220409.
14. Wortmann SB, Kluijtmans LAJ, Rodenburg RJ, et al.
3-Methylglutaconic aciduria—lessons from 50 genes and 977 patients.
J Inherit Metab Dis. 2013;36:913-921. https://doi.org/10.1007/
s10545-012-9579-6.
15. Wortmann SB, Duran M, Anikster Y, et al. Inborn errors of metab-
olism with 3-methylglutaconic aciduria as discriminative feature:
proper classification and nomenclature. J Inherit Metab Dis. 2013;
36:923-928. https://doi.org/10.1007/s10545-012-9580-0.
16. Ikon N, Ryan RO. On the origin of 3-methylglutaconic acid in
disorders of mitochondrial energy metabolism. J Inherit Metab
Dis. 2016;39:749-756. https://doi.org/10.1007/s10545-016-
9933-1.
17. Fitzsimons PE, Alston CL, Bonnen PE, et al. Clinical, biochemi-
cal, and genetic features of four patients with short-chain enoyl-
CoA hydratase (ECHS1) deficiency. Am J Med Genet A. 2018;
176:1115-1127. https://doi.org/10.1002/ajmg.a.38658.
18. Huffnagel IC, Redeker EJW, Reneman L, Vaz FM,
Ferdinandusse S, Poll-The BT. Mitochondrial encephalopathy and
transient 3-methylglutaconic aciduria in ECHS1 deficiency: long-
term follow-up. JIMD Rep. 2018;39:83-87. https://doi.org/10.
1007/8904_2017_48.
19. Kovacs-Nagy R, Morin G, Nouri M, et al. HTRA2 defect: a recog-
nizable inborn error of metabolism with 3-methylglutaconic aciduria
as discriminating feature characterized by neonatal movement disor-
der and epilepsy—report of 11 patients. Neuropediatrics. 2018;49:
373-378. https://doi.org/10.1055/s-0038-1667345.
20. Bartsakoulia M, Mϋller JS, Gomez-Duran A, Yu-Wai-Man P,
Boczonadi V, Horvath R. Cysteine supplementation may be beneficial
in a subgroup of mitochondrial translation deficiencies. J Neuromuscul
Dis. 2016;3:363-379. https://doi.org/10.3233/JND-160178.
SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section at the end of this article.
How to cite this article: Coelho MP, Correia J,
Dias A, et al. Iron-sulfur cluster ISD11 deficiency
(LYRM4 gene) presenting as cardiorespiratory arrest
and 3-methylglutaconic aciduria. JIMD Reports.
2019;49:11–16. https://doi.org/10.1002/jmd2.12058
16 COELHO ET AL.
